- China
- /
- Medical Equipment
- /
- SZSE:300206
Following recent decline, Edan Instruments, Inc.'s (SZSE:300206) top shareholder CEO Hao Zhang sees holdings value drop by 6.6%
Key Insights
- Edan Instruments' significant insider ownership suggests inherent interests in company's expansion
- 55% of the business is held by the top 3 shareholders
- Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
Every investor in Edan Instruments, Inc. (SZSE:300206) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 55% to be precise, is individual insiders. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
And last week, insiders endured the biggest losses as the stock fell by 6.6%.
Let's take a closer look to see what the different types of shareholders can tell us about Edan Instruments.
Check out our latest analysis for Edan Instruments
What Does The Institutional Ownership Tell Us About Edan Instruments?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
Institutions have a very small stake in Edan Instruments. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. If the business gets stronger from here, we could see a situation where more institutions are keen to buy. It is not uncommon to see a big share price rise if multiple institutional investors are trying to buy into a stock at the same time. So check out the historic earnings trajectory, below, but keep in mind it's the future that counts most.
We note that hedge funds don't have a meaningful investment in Edan Instruments. Looking at our data, we can see that the largest shareholder is the CEO Hao Zhang with 21% of shares outstanding. The second and third largest shareholders are Youdong Zu and Xicheng Xie, with an equal amount of shares to their name at 17%. Note that two of the top three shareholders are also Chief Financial Officer and Member of the Board of Directors, respectively, once again pointing to significant ownership by company insiders.
After doing some more digging, we found that the top 3 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.
Insider Ownership Of Edan Instruments
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
Our most recent data indicates that insiders own the majority of Edan Instruments, Inc.. This means they can collectively make decisions for the company. So they have a CN¥4.0b stake in this CN¥7.3b business. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.
General Public Ownership
The general public-- including retail investors -- own 40% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
Next Steps:
It's always worth thinking about the different groups who own shares in a company. But to understand Edan Instruments better, we need to consider many other factors. To that end, you should learn about the 3 warning signs we've spotted with Edan Instruments (including 1 which makes us a bit uncomfortable) .
If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Valuation is complex, but we're here to simplify it.
Discover if Edan Instruments might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300206
Edan Instruments
Engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally.
Flawless balance sheet average dividend payer.
Market Insights
Community Narratives


